ArticleVeterinary research communications2026
Deoxynivalenol-induced apoptosis and IL-1β modulation by fosfomycin in porcine immune and human intestinal epithelial cells.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Deoxynivalenol is a trichothecene mycotoxin found in cereals and animal feed, causing immunotoxic and cytotoxic effects in both animals and humans. In pigs, deoxynivalenol induces immune cell apoptosis, while in humans it disrupts cytokine expression and gut barrier function. Fosfomycin is a broad-spectrum antibiotic with immunomodulatory and antimicrobial properties. The aim of this study was to evaluate the effects of fosfomycin on deoxynivalenol-induced apoptosis and on the expression of the proinflammatory cytokine interleukin-1 beta (IL-1β), in pig and human cells, respectively. Porcine adherent mononuclear cells were exposed to deoxynivalenol, fosfomycin, or their combination for 4 h while Caco-2 cells were treated for 24 h. Nuclear apoptotic changes in porcine cells were assessed by DAPI staining and cell death was confirmed by TUNEL assay. IL-1β gene expression in Caco-2 cells was evaluated by RT-qPCR. Deoxynivalenol significantly increased nuclear morphological alterations and the percentage of apoptotic cells in porcine mononuclear cells compared with untreated controls (p < 0.01). Co-treatment with fosfomycin prevented DON-induced apoptosis, restoring apoptotic levels to those observed in controls, and markedly reduced IL-1β expression in Caco-2 cells. Fosfomycin exerts a protective effect against deoxynivalenol-induced apoptosis and proinflammatory response, suggesting its potential as modulator of mycotoxin-induced cellular damage in both veterinary and biomedical contexts.
Indexed as
Identifiers
41609953What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.